Pathway Financial Advisors LLC Merck & Co., Inc. Transaction History

Pathway Financial Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$123.8 - $132.96 $4,704 - $5,052	-38 Reduced 1.65%	2,270 $281,000
Q1 2024 Apr 10, 2024	BUY	$113.24 - $131.95 $38,841 - $45,258	343 Added 17.46%	2,308 $304,000
Q4 2023 Jan 31, 2024	BUY	$100.18 - $109.02 $196,853 - $214,224	1,965 New	1,965 $214,000
Q2 2020 Jul 21, 2020	SELL	$70.42 - $80.13 $239,428 - $272,442	-3,400 Closed	0 $0
Q4 2019 Jan 22, 2020	BUY	$77.58 - $87.54 $263,772 - $297,636	3,400 New	3,400 $306,000
Q3 2018 Jan 16, 2019	SELL	$57.69 - $67.84 $72,458 - $85,207	-1,256 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$50.83 - $59.72 $12,707 - $14,930	-250 Reduced 16.6%	1,256 $76,000
Q4 2017 May 04, 2018	BUY	$51.62 - $61.64 $77,739 - $92,829	1,506	1,506 $85,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Pathway Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pathway Financial Advisors LLC with notifications on news.